PTC Therapeutics, Inc.PTC Therapeutics, Inc.PTC Therapeutics, Inc.

PTC Therapeutics, Inc.

No trades
See on Supercharts
Market capitalization
‪1.93 B‬USD
−8.37USD
‪−626.60 M‬USD
‪937.82 M‬USD
‪73.71 M‬
Beta (1Y)
1.37

About PTC Therapeutics, Inc.

CEO
Matthew B. Klein
Headquarters
South Plainfield
Website
Employees (FY)
995
Founded
1998
ISIN
US69366J2006
FIGI
BBG000QT15P7
PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. The company was founded by Allan Steven Jacobson and Stuart Walter Peltz on March 31, 1998 and is headquartered in South Plainfield, NJ.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of PTCT is 24.69 USD — it has decreased by 1.87% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange PTC Therapeutics, Inc. stocks are traded under the ticker PTCT.
PTC Therapeutics, Inc. is going to release the next earnings report on Apr 25, 2024. Keep track of upcoming events with our Earnings Calendar.
PTCT stock is 3.31% volatile and has beta coefficient of 1.37. Check out the list of the most volatile stocks — is PTC Therapeutics, Inc. there?
One year price forecast for PTC Therapeutics, Inc. has a max estimate of 45.00 USD and a min estimate of 15.00 USD.
PTCT earnings for the last quarter are −1.76 USD whereas the estimation was −1.06 USD which accounts for −65.26% surprise. Estimated earnings for the next quarter are −0.14 USD. See more details about PTC Therapeutics, Inc. earnings.
PTC Therapeutics, Inc. revenue for the last quarter amounts to ‪196.58 M‬ USD despite the estimated figure of ‪210.23 M‬ USD. In the next quarter revenue is expected to reach ‪314.96 M‬ USD.
Yes, you can track PTC Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
PTCT stock has fallen by 10.05% compared to the previous week, the month change is a 14.66% fall, over the last year PTC Therapeutics, Inc. has showed a 53.16% decrease.
PTCT net income for the last quarter is ‪−155.79 M‬ USD, while the quarter before that showed ‪−132.97 M‬ USD of net income which accounts for −17.16% change. Track more PTC Therapeutics, Inc. financial stats to get the full picture.
Today PTC Therapeutics, Inc. has the market capitalization of ‪1.93 B‬, it has decreased by 5.35% over the last week.
No, PTCT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PTCT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PTC Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
PTCT reached its all-time high on Apr 9, 2015 with the price of 78.72 USD, and its all-time low was 4.03 USD and was reached on Nov 3, 2016.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has 995.00 employees. See our rating of the largest employees — is PTC Therapeutics, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PTC Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PTC Therapeutics, Inc. stock shows the strong sell signal. See more of PTC Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on PTC Therapeutics, Inc. future price: according to them, PTCT price has a max estimate of 45.00 USD and a min estimate of 15.00 USD. Read a more detailed PTC Therapeutics, Inc. forecast: see what analysts think of PTC Therapeutics, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PTC Therapeutics, Inc. EBITDA is ‪−104.66 M‬ USD, and current EBITDA margin is −12.03%. See more stats in PTC Therapeutics, Inc. financial statements.